Arsenic Exposure
3
0
0
3
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
5 treatments under study, led by Sodium Selenite
Research Leaders
6 sponsors active, led by Texas Tech University
Related Conditions
Often studied with 6 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 30/100
0.0%
0 terminated out of 3 trials
100.0%
+13.4% vs benchmark
33%
1 trials in Phase 3/4
0%
0 of 3 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 3 completed trials
Clinical Trials (3)
Returning Genetic Results on Arsenic Susceptibility
Nutrition, Arsenic and Cognitive Function in Children
Selenium in the Treatment of Arsenic Toxicity and Cancers
Research Network
Common Treatments
- Sodium Selenite1
- Folic Acid1
- Standard Information On Arsenic Exposure Reduction1
- Personal Information On Genetic Susceptibility To Arsenic Toxicity1
- Vitamin B121
Active Sponsors
- Texas Tech University1
- American Cancer Society, Inc.1
- Columbia University1
- National Cancer Institute (NCI)1
- National Institute of Environmental Health Sciences (NIEHS)1
Top Investigators
Columbia University
Texas Tech University
Institute of Child & Mother Health, Dhaka, Bangladesh
Pritzker School of Medicine, The University of Chicago
Related Conditions
- Arsenic Toxicity1
- Arsenical Keratosis1
- Arsenical Cancers1
- Arsenic Poisoning1
- Arsenical Melanosis1